Literature DB >> 17657167

Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.

Xiao-ming He1, Zhen-xin Zhang, Jun-wu Zhang, Yong-tao Zhou, Mou-ni Tang, Cheng-bin Wu, Zhen Hong.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by excessive neuronal loss in specific regions of the brain. Among the areas most severely affected are the basal forebrain cholinergic neurons and their projection regions, the hippocampus and the cortex. Several lines of evidence have made brain-derived neurotrophic factor (BDNF) an important candidate gene conferring risk for AD. Recently, several reports investigated the association between a single nucleotide polymorphism (Val66Met, rs6265) of the BDNF gene and AD but yielded ambiguous results. To figure out the association of this single nucleotide polymorphism in the BDNF gene with sporadic AD in a Chinese Han population, we analyzed 513 patients with AD and 575 controls for the genetic association studies. Our results indicated that the distribution of the BDNF genotypes and alleles did not differ significantly. Similar results were observed when the AD and control groups were stratified by age/age at onset and sex. Our data also showed that in the Chinese Han population, the frequencies of the BDNF Met allele (46.5%) and Val allele (53.5%) were significantly different from ethnic groups from Italy, Japan and the USA. The present data revealed no significant effect of the genotypes on the age at onset for developing AD, and no significant association between the genotypes and the severity of the disease. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657167     DOI: 10.1159/000106473

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  15 in total

1.  Association of BDNF Polymorphisms with the Risk of Epilepsy: a Multicenter Study.

Authors:  Hidayati Mohd Sha'ari; Batoul Sadat Haerian; Larry Baum; Hui Jan Tan; Mohd Hanip Rafia; Patrick Kwan; Stacey S Cherny; Pak Chung Sham; Hongsheng Gui; Azman Ali Raymond; Kheng Seang Lim; Zahurin Mohamed
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

2.  Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression.

Authors:  Luye Qin; Eunhee Kim; Rajiv Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

3.  Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

Authors:  Huihui Ji; Dongjun Dai; Yunliang Wang; Danjie Jiang; Xingyu Zhou; Peipei Lin; Xiaosui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Rongrong Chen; Lina Zhang; Mingqing Xu; Shiwei Duan; Qinwen Wang
Journal:  Exp Ther Med       Date:  2015-03-03       Impact factor: 2.447

4.  An adaptive role for BDNF Val66Met polymorphism in motor recovery in chronic stroke.

Authors:  Luye Qin; Deqiang Jing; Sarah Parauda; Jason Carmel; Rajiv R Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

5.  Involvement of BDNF in age-dependent alterations in the hippocampus.

Authors:  Oliver von Bohlen und Halbach
Journal:  Front Aging Neurosci       Date:  2010-08-13       Impact factor: 5.750

6.  Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants.

Authors:  Nela Pivac; Byungsu Kim; Gordana Nedić; Yeon Ho Joo; Dragica Kozarić-Kovacić; Jin Pyo Hong; Dorotea Muck-Seler
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

7.  BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study.

Authors:  Kristina F Zdanys; Timothy G Kleiman; Huiping Zhang; Fatih Ozbay; Martha G MacAvoy; Joel Gelernter; Christopher H van Dyck
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 8.  CD36 as a therapeutic target for endothelial dysfunction in stroke.

Authors:  Sunghee Cho
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 9.  Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer's Disease: Beneficial Effects of Flavonoids for Neuroprotection.

Authors:  Tadahiro Numakawa; Haruki Odaka
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals.

Authors:  M Millan Sanchez; D Das; J L Taylor; A Noda; J A Yesavage; A Salehi
Journal:  Transl Psychiatry       Date:  2011-10-25       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.